Skip to main content
Premium Trial:

Request an Annual Quote

NEWSBRIEF: Third Wave Technologies Reports Lowered Revenue, Widened Losses For Q1

NEW YORK, May 7-Gene analysis equipment company Third Wave Technologies today reported declining revenues and increased losses for the first quarter of 2002.


For the three months ended March 31, the company reported revenues of $10.1 million, down from $11.2 during the same period last year.


Net losses climbed to $7.3 million for the quarter, or 19 cents per diluted share, from $5.9 million (20 cents per diluted share) during the first quarter of 2001.


Revenues came primarily from Third Wave's Invader SNP and gene analysis products, which slumped from $10.2 million during the first quarter of 2001 to $9.4 million during the quarter just ended.


The company boosted R&D spending to $4.4 million in the quarter, up from $2.9 million in the same period last year, while keeping overall operating expenses nearly constant ($17.4 million in this quarter compared with $17.7 in the equivalent quarter last year).


Third Wave held cash, cash equivalents and short-term investments of $66.5 million at the end of the quarter, down 9 percent from holdings of $73.3 million at the end of the first quarter of 2001.

The Scan

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.

Study Looks at Parent Uncertainties After Children's Severe Combined Immunodeficiency Diagnoses

A qualitative study in EJHG looks at personal, practical, scientific, and existential uncertainties in parents as their children go through SCID diagnoses, treatment, and post-treatment stages.

Antimicrobial Resistance Study Highlights Key Protein Domains

By screening diverse versions of an outer membrane porin protein in Vibrio cholerae, researchers in PLOS Genetics flagged protein domain regions influencing antimicrobial resistance.

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.